NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026)

NovoCure (NVCR) posted quarterly Amortizatization of Intangibles of -$2.6 million for Q2 2026, up 59.86% year-on-year from -$1.6 million in Q2 2025, and up 0.92% on a QoQ basis from -$2.6 million in Q1 2026.

NovoCure (NVCR) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

NovoCure (NVCR) has reported Amortizatization of Intangibles for 13 consecutive years, with -$2.6 million the latest figure, recorded in Q2 2026.

  • Quarterly Amortizatization of Intangibles rose 59.86% year-over-year to -$2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$15.4 million (up 42.1% YoY) and the FY2025 annual result came in at -$23.3 million, up 9.29% from the prior year.
  • Amortizatization of Intangibles climbed to -$2.6 million in Q2 2026 per NVCR's latest filing, from -$2.6 million in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for NVCR reached as high as $827000.0 in Q2 2022 and fell as low as -$7.3 million in Q4 2023.
  • A 5-year average of -$4.4 million and a median of -$5.2 million in 2023 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles plunged 2984.05% — and 2026, when it jumped 60.67%.
  • Year by year, Amortizatization of Intangibles stood at -$3.3 million in 2022, then tumbled by 121.47% to -$7.3 million in 2023, then rose by 8.12% to -$6.7 million in 2024, then soared by 43.85% to -$3.7 million in 2025, then soared by 30.78% to -$2.6 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$2.6 million, -$2.6 million, and -$3.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 NovoCure 1.97 Bn 1.53 Bn 142.48 Mn -2.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.59 Mn
Jun 30, 2026 -2.59 Mn
Mar 31, 2026 -2.62 Mn
Mar 31, 2026 -2.62 Mn
Dec 31, 2025 -3.75 Mn
Dec 31, 2025 -3.75 Mn
Sep 30, 2025 -6.40 Mn
Sep 30, 2025 -6.40 Mn
Jun 30, 2025 -6.46 Mn
Jun 30, 2025 -6.46 Mn
Mar 31, 2025 -6.65 Mn
Mar 31, 2025 -6.65 Mn
Dec 31, 2024 -6.67 Mn
Dec 31, 2024 -6.67 Mn
Sep 30, 2024 -6.74 Mn
Sep 30, 2024 -6.74 Mn
Jun 30, 2024 -6.85 Mn
Jun 30, 2024 -6.85 Mn
Mar 31, 2024 -5.38 Mn
Mar 31, 2024 -5.38 Mn